Hubei Jumpcan Pharmaceutical Co., Ltd.

SHSE:600566 Stock Report

Market Cap: CN¥24.2b

Hubei Jumpcan Pharmaceutical (600566) Stock Overview

Engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. More details

600566 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends3/6

600566 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Hubei Jumpcan Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Hubei Jumpcan Pharmaceutical
Historical stock prices
Current Share PriceCN¥26.32
52 Week HighCN¥34.46
52 Week LowCN¥23.85
Beta0.075
1 Month Change-4.33%
3 Month Change-0.11%
1 Year Change-18.29%
3 Year Change4.86%
5 Year Change-2.88%
Change since IPO32.86%

Recent News & Updates

Is Hubei Jumpcan Pharmaceutical (SHSE:600566) Using Too Much Debt?

Mar 19
Is Hubei Jumpcan Pharmaceutical (SHSE:600566) Using Too Much Debt?

Recent updates

Is Hubei Jumpcan Pharmaceutical (SHSE:600566) Using Too Much Debt?

Mar 19
Is Hubei Jumpcan Pharmaceutical (SHSE:600566) Using Too Much Debt?

Hubei Jumpcan Pharmaceutical (SHSE:600566) Ticks All The Boxes When It Comes To Earnings Growth

Jan 27
Hubei Jumpcan Pharmaceutical (SHSE:600566) Ticks All The Boxes When It Comes To Earnings Growth

Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Prospects Need A Boost To Lift Shares

Dec 31
Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Prospects Need A Boost To Lift Shares

Does Hubei Jumpcan Pharmaceutical (SHSE:600566) Have A Healthy Balance Sheet?

Dec 10
Does Hubei Jumpcan Pharmaceutical (SHSE:600566) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) 26% Share Price Plunge

Sep 11
Why Investors Shouldn't Be Surprised By Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) 26% Share Price Plunge

An Intrinsic Calculation For Hubei Jumpcan Pharmaceutical Co., Ltd. (SHSE:600566) Suggests It's 45% Undervalued

Sep 09
An Intrinsic Calculation For Hubei Jumpcan Pharmaceutical Co., Ltd. (SHSE:600566) Suggests It's 45% Undervalued

Is Hubei Jumpcan Pharmaceutical (SHSE:600566) A Risky Investment?

Aug 07
Is Hubei Jumpcan Pharmaceutical (SHSE:600566) A Risky Investment?

Is Now The Time To Put Hubei Jumpcan Pharmaceutical (SHSE:600566) On Your Watchlist?

Jul 01
Is Now The Time To Put Hubei Jumpcan Pharmaceutical (SHSE:600566) On Your Watchlist?

Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Prospects Need A Boost To Lift Shares

May 30
Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Prospects Need A Boost To Lift Shares

Hubei Jumpcan Pharmaceutical (SHSE:600566) Ticks All The Boxes When It Comes To Earnings Growth

Mar 17
Hubei Jumpcan Pharmaceutical (SHSE:600566) Ticks All The Boxes When It Comes To Earnings Growth

Shareholder Returns

600566CN PharmaceuticalsCN Market
7D1.7%3.0%1.8%
1Y-18.3%27.5%25.6%

Return vs Industry: 600566 underperformed the CN Pharmaceuticals industry which returned 27.5% over the past year.

Return vs Market: 600566 underperformed the CN Market which returned 25.6% over the past year.

Price Volatility

Is 600566's price volatile compared to industry and market?
600566 volatility
600566 Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement5.0%
10% most volatile stocks in CN Market8.5%
10% least volatile stocks in CN Market2.8%

Stable Share Price: 600566 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600566's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a5,026Fei Caowww.jumpcan.com

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, neurology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.

Hubei Jumpcan Pharmaceutical Co., Ltd. Fundamentals Summary

How do Hubei Jumpcan Pharmaceutical's earnings and revenue compare to its market cap?
600566 fundamental statistics
Market capCN¥24.24b
Earnings (TTM)CN¥2.13b
Revenue (TTM)CN¥7.14b
11.4x
P/E Ratio
3.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600566 income statement (TTM)
RevenueCN¥7.14b
Cost of RevenueCN¥1.56b
Gross ProfitCN¥5.58b
Other ExpensesCN¥3.45b
EarningsCN¥2.13b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 23, 2025

Earnings per share (EPS)2.31
Gross Margin78.15%
Net Profit Margin29.79%
Debt/Equity Ratio4.6%

How did 600566 perform over the long term?

See historical performance and comparison

Dividends

7.9%
Current Dividend Yield
90%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/15 08:29
End of Day Share Price 2025/07/15 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hubei Jumpcan Pharmaceutical Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bin WuChina Merchants Securities Co. Ltd.
Lan LanFounder Securities Co., Ltd.
Wen DaiHuatai Research